As epiretinal membranes (ERMs), the internal limiting membrane (ILM) and the vitreous cortex are essentially transparent tissues, or translucent structures, nontraumatic removal may be challenging in various types of macular surgery. Vital dyes stain these thin tissues, thus allowing for better visualization of these structures during vitrectomy and selective ‘membrane peeling' from the underlying retina. To avoid swirling of the dye within the fluid-filled vitreous cavity, and to better target the dye onto the macula, a fluid-air exchange is commonly performed. However, this may jeopardize visualization of the macula during peeling due to clouding of the posterior lens capsule, and may lead to postoperative visual field defects. Recently, a new dye solution for staining the ERM and ILM simultaneously has been developed that circumvents the need for fluid-air exchange, i.e. MembraneBlue-Dual™. This paper will focus on the hydrodynamics and biocompatibility of this ‘heavy' dual dye and its efficacy for staining of the ILM and/or ERMs during posterior segment surgery in a multicenter clinical setting.

1.
Eckardt C, Eckardt U, Groos S, Luciano L, Reale E: Removal of the internal limiting membrane in macular holes. Clinical and morphological findings. Ophthalmologe 1997;94:545-551.
2.
Olsen TW, Sternberg P Jr, Capone A Jr, Martin DF, Lim JI, Grossniklaus HE, Aaberg TM Sr: Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane. Retina 1998;18:322-329.
3.
Park DW, Sipperley JO, Sneed SR, Dugel PU, Jacobsen J: Macular hole surgery with internal-limiting membrane peeling and intravitreous air. Ophthalmology 1999;106:1392-1397, discussion 1397-1398.
4.
Rodrigues EB, Costa EF, Penha FM, Melo GB, Bottós J, Dib E, Furlani B, Lima VC, Maia M, Meyer CH, Höfling-Lima AL, Farah ME: The use of vital dyes in ocular surgery. Surv Ophthalmol 2009;54:576-617.
5.
Kwok AK, Lai TY, Yuen KS: Epiretinal membrane surgery with or without internal limiting membrane peeling. Clin Experiment Ophthalmol 2005;33:379-385.
6.
Shimada H, Nakashizuka H, Hattori T, Mori R, Mizutani Y, Yuzawa M: Double staining with brilliant blue G and double peeling for epiretinal membranes. Ophthalmology 2009;116:1370-1376.
7.
Gandorfer A, Haritoglou C, Scheler R, Schumann R, Zhao F, Kampik A: Residual cellular proliferation on the internal limiting membrane in macular pucker surgery. Retina 2012;32:477-485.
8.
Ueno S, Kondo M, Piao CH, Ikenoya K, Miyake Y, Terasaki H: Selective amplitude reduction of the PhNR after macular hole surgery: ganglion cell damage related to ICG-assisted ILM peeling and gas tamponade. Invest Ophthalmol Vis Sci 2006;47:3545-3549.
9.
Abrams GW, Topping T, Machemer R: An improved method for practice vitrectomy. Arch Ophthalmol 1978;96:521-525.
10.
Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE: Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000;107:2010-2014.
11.
Kadonosono K, Itoh N, Uchio E, et al: Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-1118.
12.
Stalmans P, Parys-van Ginderdeuren R, De Vos R, Feron EJ: ICG staining of the inner limiting membrane facilitates its removal during surgery for macular holes and puckers. Bull Soc Belge Ophthalmol 2001;281:21-26.
13.
Gandorfer A, Messmer EM, Ulbig MW, Kampik A: Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol 2001;131:387-388.
14.
Kwok AK, Li WW, Pang CP, et al: Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 2001;132:178-183.
15.
Da Mata AP, Burk SE, Riemann CD, et al: Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 2001;108:1187-1192.
16.
Kusaka S, Hayashi N, Ohji M, et al: Indocyanine green facilitates removal of epiretinal and internal limiting membranes in myopic eyes with retinal detachment. Am J Ophthalmol 2001;131:388-390.
17.
Gandorfer A, Haritoglou C, Gass CA, et al: Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 2001;132:431-433.
18.
Engelbrecht NE, Freeman J, Sternberg P Jr, et al: Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2002;133:89-94.
19.
Weinberger AW, Kirchhoff B, Mazinani BE, Schrage NF: Persistent indocyanine green (ICG) fluorescence 6 weeks after intraocular ICG administration for macular hole surgery. Graefes Arch Clin Exp Ophthalmol 2001;239:388-390.
20.
Sippy BD, Engelbrecht NE, Hubbart GB, et al: Indocyanine green effect on cultured human retinal pigment epithelial cells: implication for macular hole surgery. Am J Ophthalmol 2001;132:433-435.
21.
Rodrigues EB, Maia M, Meyer CH, Penha FM, Dib E, Farah ME: Vital dyes for chromovitrectomy. Curr Opin Ophthalmol 2007;18:179-187.
22.
Rodrigues EB, Penha FM, de Paula Fiod Costa E, Maia M, Dib E, Moraes M Jr, Meyer CH, Magalhaes O Jr, Melo GB, Stefano V, Dias AB, Farah ME: Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery. Am J Ophthalmol 2010;149:265-277.
23.
Teba FA, Mohr A, Eckardt C, Wong D, Kusaka S, Joondeph BC, Feron EJ, Stalmans P, Van Overdam K, Melles GR: Trypan blue staining in vitreoretinal surgery. Ophthalmology 2003;110:2409-2412.
24.
Enaida H, Hisatomi T, Goto Y, Hata Y, Ueno A, Miura M, Kubota T, Ishibashi T: Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina 2006;26:623-630.
25.
Enaida H, Hisatomi T, Hata Y, Ueno A, Goto Y, Yamada T, Kubota T, Ishibashi T: Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 2006;26:631-636.
26.
Awad D, Schrader I, Bartok M, Mohr A, Gabel D: Comparative toxicology of trypan blue, brilliant blue G, and their combination together with polyethylene glycol on human pigment epithelial cells. Invest Ophthalmol Vis Sci 2011;52:4085-4090.
27.
Melles GR, de Waard PW, Pameyes JH, Houdijn Beekhuis W: Trypan blue capsule staining to visualize the capsulorhexis in cataract surgery. J Cataract Refract Surg 1999;25:7-9.
28.
Veckeneer M, van Overdam KA, Monzer J, et al: Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2001;239:698-704.
29.
Feron EJ, Veckeneer M, Parys-van Ginderdeuren R, et al: Trypan blue staining of internal limiting membranes in proliferative vitreoretinopathy. Arch Ophthalmol 2002;120:141-144.
30.
Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J: Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol 2003;87:216-219.
31.
Stalmans P, van Aken EH, Melles GRJ, et al: Trypan blue is nontoxic for retinal pigment epithelium in vitro. Am J Ophthalmol 2003;135:234-236.
32.
Westermeier R: Sensitive, quantitative, and fast modifications for Coomassie blue staining of polyacrylamide gels. Proteomics 2006;6(suppl 2):61-64.
33.
Henrich PB, Priglinger SG, Haritoglou C, Josifova T, Ferreira PR, Strauss RW, Flammer J, Cattin PC: Quantification of contrast recognizability during brilliant blue G- and indocyanine green-assisted chromovitrectomy. Invest Ophthalmol Vis Sci 2011;52:4345-4349.
34.
Cervera E, Díaz-Llopis M, Salom D, Udaondo P: High dose intravitreal brilliant blue G. Arch Soc Esp Oftalmol 2007;82:473.
35.
Yuen D, Gonder J, Proulx A, Liu H, Hutnik C: Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and indocyanine green. Am J Ophthalmol 2009;147:251-259.
36.
Stalmans P, Feron EJ, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Veckeneer M: Double vital staining using trypan blue and infracyanine green in macular pucker surgery. Br J Ophthalmol 2003;87:713-716.
37.
Kwok AK, Lai TY, Li WW, Yew DT, Wong VW: Trypan blue- and indocyanine green-assisted epiretinal membrane surgery: clinical and histopathological studies. Eye (Lond) 2004;18:882-888.
38.
Hirata A, Yonemura N, Hasumura T, Murata Y, Negi A: Effect of infusion air pressure on visual field defects after macular hole surgery. Am J Ophthalmol 2000;130:611-616.
39.
Hasumura T, Yonemura N, Hirata A, et al: Retinal damage by air infusion during vitrectomy in rabbit eyes. Invest Ophthalmol Vis Sci 2000;41:4300-4304.
40.
Yang SS, McDonald HR, Everett AI, et al: Retinal damage caused by air-fluid exchange during pars plana vitrectomy. Retina 2006;26:334-338.
41.
Lesnik Oberstein SY, Mura M, Tan SH, de Smet MD: Heavy trypan blue staining of epiretinal membranes: an alternative to infracyanine green. Br J Ophthalmol 2007;91:955-957.
42.
Costa EP, Rodrigues EB, Farah ME, et al: Vital dyes and light sources for chromovitrectomy: comparative assessment of osmolarity, pH, and spectrophotometry. Invest Ophthalmol Vis Sci 2009;50:385-391.
43.
Melles GRJ: The use of a vital dye for facilitating surgical procedures for vitreoretinal surgery. 2004. Patent WO 99/58159 and US 6,696,430.
44.
Gerding H, Timmermann M, Thelen U: Intravital staining of the internal limiting membrane with a novel heavy solution of brilliant blue G. Klin Monatsbl Augenheilkd 2011;228:298-301.
45.
Januschowski K, Mueller S, Spitzer MS, Schramm C, Doycheva D, Bartz-Schmidt KU, Szurman P: Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin. Graefes Arch Clin Exp Ophthalmol 2012;250:1013-1022.
46.
Di Palma JA, Cleveland MV, McGowan J, Herrera JL: A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation. Am J Gastroenterol 2007;102:1964-1971.
47.
Lüke C, Lüke M, Dietlein TS, Hueber A, Jordan J, Sickel W, Kirchhof B: Retinal tolerance to dyes. Br J Ophthalmol 2005;89:1188-1191.
48.
Jin Y, Uchida S, Yanagi Y, Aihara M, Araie M: Neurotoxic effects of trypan blue on rat retinal ganglion cells. Exp Eye Res 2005;81:395-400.
49.
Morales MC, Freire V, Asumendi A, Araiz J, Herrera I, Castiella G, Corcóstegui I, Corcóstegui G: Comparative effects of six intraocular vital dyes on retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2010;51:6018-6029.
50.
Jackson TL, Hillenkamp J, Knight BC, Zhang JJ, Thomas D, Stanford MR, Marshall J: Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004;45:2778-2785.
51.
Perrier M, Sébag M: Trypan blue-assisted peeling of the internal limiting membrane during macular hole surgery. Am J Ophthalmol 2003;135:903-905.
52.
Perrier M, Sébag M: Epiretinal membrane surgery assisted by trypan blue. Am J Ophthalmol 2003;135:909-911.
53.
Vote BJ, Russell MK, Joondeph BC: Trypan blue-assisted vitrectomy. Retina 2004;24:736-738.
54.
Haritoglou C, Eibl K, Schaumberger M, et al: Functional outcome after trypan blue-assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial. Am J Ophthalmol 2004;138:1-5.
55.
Haritoglou C, Gandorfer A, Gass CA, Kampik A: Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5% diluted indocyanine and infracyanine green. Am J Ophthalmol 2004;137:345-348.
56.
Haritoglou C, Tadayoni R, May CA, Gass CA, Freyer W, Priglinger SG, Kampik A: Short-term in vivo evaluation of novel vital dyes for intraocular surgery. Retina 2006;26:673-678.
57.
Mackenzie SE, Gandorfer A, Rohleder M, Schumann R, Schlottmann PG, Bunce C, Xing W, Gregor Z, Charteris DG: Ultrastructure and retinal imaging of internal limiting membrane: a clinicopathologic correlation of trypan blue stain in macular hole surgery. Retina 2010;30:655-661.
58.
Kawahara S, Hata Y, Miura M, Kita T, Sengoku A, Nakao S, Mochizuki Y, Enaida H, Ueno A, Hafezi-Moghadam A, Ishibashi T: Intracellular events in retinal glial cells exposed to ICG and BBG. Invest Ophthalmol Vis Sci 2007;48:4426-4432.
59.
Iriyama A, Kadonosono K, Tamaki Y, Yanagi Y: Effect of brilliant blue G on the retinal ganglion cells of rats. Retina 2012;32:613-616.
60.
Ueno A, Hisatomi T, Enaida H, Kagimoto T, Mochizuki Y, Goto Y, Kubota T, Hata Y, Ishibashi T: Biocompatibility of brilliant blue G in a rat model of subretinal injection. Retina 2007;27:499-504.
61.
Ejstrup R, la Cour M, Heegaard S, Kiilgaard JF: Toxicity profiles of subretinal indocyanine green, brilliant blue G, and triamcinolone acetonide: a comparative study. Graefes Arch Clin Exp Ophthalmol 2012:250:669-677.
62.
Remy M, Thaler S, Schumann RG, May CA, Fiedorowicz M, Schuettauf F, Grüterich M, Priglinger SG, Nentwich MM, Kampik A, Haritoglou C: An in vivo evaluation of brilliant blue G in animals and humans. Br J Ophthalmol 2008;92:1142-1147.
63.
Fukuda K, Shiraga F, Yamaji H, Nomoto H, Shiragami C, Enaida H, Ishibashi T: Morphologic and functional advantages of macular hole surgery with brilliant blue G-assisted internal limiting membrane peeling. Retina 2011;31:1720-1725.
64.
Luo J, Borgens R, Shi R: Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J Neurochem 2002;83:471-480.
65.
Januschowski K, Mueller S, Spitzer MS, et al: Investigating the biocompatibility of two new heavy intraocular dyes for vitreoretinal surgery with an isolated perfused vertebrate retina organ culture model and a retinal ganglion cell line. Graefes Arch Clin Exp Ophthalmol 2012;250:533-545.
66.
Kovacević D, Mance TC, Markusić V: ‘Brilliant blue G' and ‘MembraneBlue Dual' assisted vitrectomy for macular hole. Coll Antropol 2011;35:191-193.
67.
Veckeneer M, Mohr A, Alharthi E, Azad R, Bashshur ZF, Bertelli E, Bejjani RA, Bouassida B, Bourla D, Corcóstegui Crespo I, Fahed C, Fayyad F, Mura M, Nawrocki J, Rivett K, Scharioth GB, Shkvorchenko DO, Szurman P, Van Wijck H, Wong IY, Wong DSH, Frank HJ, Oellerich S, Bruinsma M, Melles GRJ: Novel ‘heavy' dyes for retinal membrane staining during macular surgery: multicenter clinical assessment. Acta Ophthalmol 2013; E-pub ahead of print.
68.
Kifuku K, Hata Y, Kohno RI, Kawahara S, Mochizuki Y, Enaida H, Sonoda KH, Ishibashi T: Residual internal limiting membrane in epiretinal membrane surgery. Br J Ophthalmol 2009;93:1016-1019.
69.
Schumann RG, Gandorfer A, Eibl KH, Henrich PB, Kampik A, Haritoglou C: Sequential epiretinal membrane removal with internal limiting membrane peeling in brilliant blue G-assisted macular surgery. Br J Ophthalmol 2010;94:1369-1372.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.